Regnum Corp., and SevenScore Pharmaceuticals, LLC ("SevenScore"), announced the assignment of the Commercialization and License Agreement ("CLA") and a related Supply Agreement to commercialize...
CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...
